! ! Effects of Daily Kombu (Laminaria japonica) Intake on Body Composition, Blood Pressure, and Fecal Microbiota in Healthy Adult Japanese: A Randomized, Double‐Blind Study - PMC
! ! Science of Ketosis: Regain Your Metabolic Health & Age Backwards | Dr. Dominic D’Agostino - YouTube
🧠 Stay ahead with the latest in science, nutrition, and wellness by subscribing to Dr. Perlmutter’s newsletter at: www.drperlmutter.com. ✉️🌱The ketogenic d...
Doctors Debate Vaccines - Uncovering the Truth from the Noise - YouTube
Explore the real science behind childhood vaccines, long-term safety, immune system health, autism, pharma bias, adjuvants, and personalized pediatric care w...
(PDF) Low Dose Alpha-Methyl-Para-Tyrosine (AMPT) in the Treatment of Dystonia and Dyskinesia
PDF | AMPT (alpha-methyl-para-tyrosine) is an inhibitor of tyrosine hydroxylase, the rate-limiting enzyme in dopamine biosynthesis. In clinical... | Find, read and cite all the research you need on ResearchGate
Parkinson’s and Ketosis with Dr Matthew Phillips - YouTube
Dr Matthew Phillips is an expert on ketosis and in this presentation he discusses recent studies and the impact ketosis has on Parkinson's. This very inform...
This channel is dedicated to helping Persons with Parkinson's Disease to become Parkinson's Warriors fighting their disease wielding the weapon of knowledge about PD and the impact that it has on daily living.
Book 1:1 consultation with a Parkinson's Disease Expert here: https://clarity.fm/pdeducation
Explore channel memberships here:
YouTube: https://www.youtube.com/channel/UC0g3abv8hkaqZbGD8y1dfYQ/join
Patreon: https://www.patreon.com/pdeducation
If you have products that you would like for me to review on the channel please send them here:
Parkinson's Disease Education
P.O. Box 1678
Broken Arrow, OK 74013
Parkinson's New Zealand provides information, education and support to people living with Parkinson's, care partners and healthcare professionals. Parkinson's is a progressive neurological condition which affects over 12,000 New Zealanders. Although it cannot be cured, treatment is available.
Creatine monohydrate pilot in Alzheimer's: Feasibility, brain creatine, and cognition - Smith - 2025 - Alzheimer's & Dementia: Translational Research & Clinical Interventions - Wiley Online Library
BACKGROUND
Preclinical studies suggest that creatine monohydrate (CrM) improves cognition and Alzheimer's disease (AD) biomarkers. However, there is currently no clinical evidence demonstrating the ...
A just-published study provides new insight into creatine in the context of Alzheimers. For all the references/articles I cited, article is coming tomorrow!#...
OmegaXL is a powerful natural supplement shown in clinical research to support joint comfort and function? It contains more than 30 healthy fatty acids, including DHA and EPA. Give it a try, OmegaXL works!
Helium says Earth is Only ~6,000 Years Old?! - YouTube
In this fascinating interview, Del Tackett talks with geologist Dr. Andrew Snelling about helium retention in zircon crystals from New Mexico granite. While ...
Jesus gave 7 Critical Warnings to the Church in the Book of Revelation, and they are desperately needed for the present Last-Days Church. but some of the mai...
Trump Gave ULTIMATUM to ISRAEL: Enforcing DAN 9:27 Covenant? - YouTube
Trump just gave an ultimatum to Israel to agree to divide the Land of Israel in a two-state solution. Is this the enforcing of the Dan 9:27 Covenant? Is this...
Public Health Risks of PFAS-Related Immunotoxicity Are Real | Current Environmental Health Reports
Purpose of Review The discovery of per- and polyfluoroalkyl substances (PFAS) in the environment and humans worldwide has ignited scientific research, government inquiry, and public concern over numerous adverse health effects associated with PFAS exposure. In this review, we discuss the use of PFAS immunotoxicity data in regulatory and clinical decision-making contexts and question whether recent efforts adequately account for PFAS immunotoxicity in public health decision-making. Recent Findings Government and academic reviews confirm the strongest human evidence for PFAS immunotoxicity is reduced antibody production in response to vaccinations, particularly for tetanus and diphtheria. However, recent events, such as the economic analysis supporting the proposed national primary drinking water regulations and clinical monitoring recommendations, indicate a failure to adequately incorporate these data into regulatory and clinical decisions. Summary To be more protective of public health, we recommend using all relevant immunotoxicity data to inform current and future PFAS-related chemical risk assessment and regulation. Biological measures of immune system effects, such as reduced antibody levels in response to vaccination, should be used as valid and informative markers of health outcomes and risks associated with PFAS exposure. Routine toxicity testing should be expanded to include immunotoxicity evaluations in adult and developing organisms. In addition, clinical recommendations for PFAS-exposed individuals and communities should be revisited and strengthened to provide guidance on incorporating immune system monitoring and other actions that can be taken to protect against adverse health outcomes.